Cargando…
Safety of a 3-Step "Catch-Up Protocol” in Re-establishing Maintenance Dose Subcutaneous Immunotherapy (SCIT) Post Covid-19 Lockdown During Allergy Season.
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849496/ http://dx.doi.org/10.1016/j.jaci.2020.12.048 |
_version_ | 1783645314810380288 |
---|---|
author | Ogeer, Ijaz Wardha, Wardha. Bhatt, Vaidehi Wu, Vince Hosein, Saajida Seto, Tyler Gyaltsen, Tenzin |
author_facet | Ogeer, Ijaz Wardha, Wardha. Bhatt, Vaidehi Wu, Vince Hosein, Saajida Seto, Tyler Gyaltsen, Tenzin |
author_sort | Ogeer, Ijaz |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7849496 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Published by Mosby, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78494962021-02-02 Safety of a 3-Step "Catch-Up Protocol” in Re-establishing Maintenance Dose Subcutaneous Immunotherapy (SCIT) Post Covid-19 Lockdown During Allergy Season. Ogeer, Ijaz Wardha, Wardha. Bhatt, Vaidehi Wu, Vince Hosein, Saajida Seto, Tyler Gyaltsen, Tenzin J Allergy Clin Immunol Article Published by Mosby, Inc. 2021-02 2021-02-01 /pmc/articles/PMC7849496/ http://dx.doi.org/10.1016/j.jaci.2020.12.048 Text en Copyright © 2020 Published by Mosby, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Ogeer, Ijaz Wardha, Wardha. Bhatt, Vaidehi Wu, Vince Hosein, Saajida Seto, Tyler Gyaltsen, Tenzin Safety of a 3-Step "Catch-Up Protocol” in Re-establishing Maintenance Dose Subcutaneous Immunotherapy (SCIT) Post Covid-19 Lockdown During Allergy Season. |
title | Safety of a 3-Step "Catch-Up Protocol” in Re-establishing Maintenance Dose Subcutaneous Immunotherapy (SCIT) Post Covid-19 Lockdown During Allergy Season. |
title_full | Safety of a 3-Step "Catch-Up Protocol” in Re-establishing Maintenance Dose Subcutaneous Immunotherapy (SCIT) Post Covid-19 Lockdown During Allergy Season. |
title_fullStr | Safety of a 3-Step "Catch-Up Protocol” in Re-establishing Maintenance Dose Subcutaneous Immunotherapy (SCIT) Post Covid-19 Lockdown During Allergy Season. |
title_full_unstemmed | Safety of a 3-Step "Catch-Up Protocol” in Re-establishing Maintenance Dose Subcutaneous Immunotherapy (SCIT) Post Covid-19 Lockdown During Allergy Season. |
title_short | Safety of a 3-Step "Catch-Up Protocol” in Re-establishing Maintenance Dose Subcutaneous Immunotherapy (SCIT) Post Covid-19 Lockdown During Allergy Season. |
title_sort | safety of a 3-step "catch-up protocol” in re-establishing maintenance dose subcutaneous immunotherapy (scit) post covid-19 lockdown during allergy season. |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849496/ http://dx.doi.org/10.1016/j.jaci.2020.12.048 |
work_keys_str_mv | AT ogeerijaz safetyofa3stepcatchupprotocolinreestablishingmaintenancedosesubcutaneousimmunotherapyscitpostcovid19lockdownduringallergyseason AT wardhawardha safetyofa3stepcatchupprotocolinreestablishingmaintenancedosesubcutaneousimmunotherapyscitpostcovid19lockdownduringallergyseason AT bhattvaidehi safetyofa3stepcatchupprotocolinreestablishingmaintenancedosesubcutaneousimmunotherapyscitpostcovid19lockdownduringallergyseason AT wuvince safetyofa3stepcatchupprotocolinreestablishingmaintenancedosesubcutaneousimmunotherapyscitpostcovid19lockdownduringallergyseason AT hoseinsaajida safetyofa3stepcatchupprotocolinreestablishingmaintenancedosesubcutaneousimmunotherapyscitpostcovid19lockdownduringallergyseason AT setotyler safetyofa3stepcatchupprotocolinreestablishingmaintenancedosesubcutaneousimmunotherapyscitpostcovid19lockdownduringallergyseason AT gyaltsentenzin safetyofa3stepcatchupprotocolinreestablishingmaintenancedosesubcutaneousimmunotherapyscitpostcovid19lockdownduringallergyseason |